The combined enrichment of AGE-RAGE, HIF1, and RAP1 signaling is of particular interest because it implies a novel interaction between these three processes, common to all our cell lines, in a manner that has not been previously described in breast cancer. The gene discussed is HIF1A; the disease is breast carcinoma.